跳至主要内容

Biphasic Insulin Aspart 30 Therapy in Insulin-Naïve and Insulin-Experienced Patients with Type 2 Diabetes: Results from the Jordanian Subgroup of the A1chieve Study

Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51841#.VHfSm2fHRK0

Objective: To analyse the safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in a Jordanian subgroup of the 24-week, non-interventional A1chieve study. Methods: A total of 509 Jordanian patients with type 2 diabetes (392 insulin-naive and 117 insulin-experienced) starting BIAsp30, alone or in combination with oral glucose-lowering drugs, were included. Safety and effectiveness outcomes were analysed over 24 weeks. Results: Patients had a mean age of 55.8 years, body mass index of 28.8 kg/m2 and diabetes duration of 9.4 years at baseline. Two serious adverse drug reactions of hypoglycaemia were reported. The proportion of patients who reported major hypoglycaemic events decreased (2.4% at baseline vs. 0.2% at Week 24, p = 0.0039). The proportion of patients reporting overall hypoglycaemia increased marginally (6.3% at baseline vs. 9.9% at Week 24, p = 0.0378), primarily attributed to a rise in minor and nocturnal hypoglycaemia reported in insulin-naive patients. From baseline to Week 24, the mean ± SD glycated haemoglobin A1c level decreased from 9.8% ± 1.4% to 7.4% ± 0.9% (p < 0.001). Significant reductions after 24 weeks were also noted in the mean fasting plasma glucose, postprandial plasma glucose, lipids, systolic blood pressure and quality of life (all p < 0.001), while the mean body weight increased by 1.8 ± 6.5 kg (p < 0.001). Conclusion: Overall, BIAsp 30 therapy was well-tolerated and resulted in improved glycaemic control in this Jordanian subgroup over 24 weeks.
Cite this paper
Haddad, J. , Haddad, F. , Nasser, R. , Al-Shudifat, A. , Annabi, F. , Sandalci, L. and Al-Kilani, M. (2014) Biphasic Insulin Aspart 30 Therapy in Insulin-Naïve and Insulin-Experienced Patients with Type 2 Diabetes: Results from the Jordanian Subgroup of the A1chieve Study. Journal of Diabetes Mellitus, 4, 379-387. doi: 10.4236/jdm.2014.44051.
 

[1] Rawal, L.B., Tapp, R.J., Williams, E.D., Chan, C., Yasin, S. and Oldenburg, B. (2012) Prevention of Type 2 Diabetes and Its Complications in Developing Countries: A Review. International Journal of Behavioral Medicine, 19, 121-133. http://dx.doi.org/10.1007/s12529-011-9162-9
[2] International Diabetes Federation (2011) International Diabetes Federation (IDF) Diabetes Atlas. 5th Edition, IDF, Brussels.
[3] Zindah, M., Belbeisi, A., Walke, H. and Mokdad, A.H. (2008) Obesity and Diabetes in Jordan: Findings from the Behavioral Risk Factors Surveillance System, 2004. Preventing Chronic Disease, 5, A17.
[4] Khattab, M., Khader, Y.S., Al-Khawaldeh, A. and Ajlouni, K. (2010) Factors Associated with Poor Glycemic Control among Patients with Type 2 Diabetes. Journal of Diabetes and Its Complications, 24, 84-89. http://dx.doi.org/10.1016/j.jdiacomp.2008.12.008
[5] Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., Diamant, M., Ferrannini, E., Nauck, M., et al. (2012) Management of Hyperglycaemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia, 55, 1577-1596. http://dx.doi.org/10.1007/s00125-012-2534-0
[6] Brunton, S. (2009) Safety and Effectiveness of Modern Insulin Therapy: The Value of Insulin Analogs. Consultant, 49, S13-S19.
[7] Halimi, S., Raskin, P., Liebl, A., Kawamori, R., Fulcher, G. and Yan, G. (2005) Efficacy of Biphasic Insulin Aspart in Patients with Type 2 Diabetes. Clinical Therapeutics, 27, S57-S74.
http://dx.doi.org/10.1016/j.clinthera.2005.11.021
[8] Davidson, J., Vexiau, P., Cucinotta, D., Vaz, J. and Kawamori, R. (2005) Biphasic Insulin Aspart 30: Literature Review of Adverse Events Associated with Treatment. Clinical Therapeutics, 27, S75-S88. http://dx.doi.org/10.1016/j.clinthera.2005.11.022
[9] Davidson, J.A., Liebl, A., Christiansen, J.S., Fulcher, G., Ligthelm, R.J., Brown, P., et al. (2009) Risk for Nocturnal Hypoglycemia with Biphasic Insulin Aspart 30 Compared with Biphasic Human Insulin 30 in Adults with Type 2 Diabetes Mellitus: A Meta-Analysis. Clinical Therapeutics, 31, 1641-1651.
http://dx.doi.org/10.1016/j.clinthera.2009.08.011
[10] Liebl, A., Prusty, V., Valensi, P., Kawamori, R., Christiansen, J.S., Palmer, A.J., Balschmidt, P., Ligthelm, R. and Mohan, V. (2012) Ten Years of Experience with Biphasic Insulin Aspart 30: From Drug Development to the Latest Clinical Findings. Drugs, 72, 1495-1520.
http://dx.doi.org/10.2165/11635490-000000000-00000
[11] Home, P., Naggar, N.E., Khamseh, M., Gonzalez-Galvez, G., Shen, C., Chakkarwar, P., et al. (2011) An Observational Non-Interventional Study of Patients with Diabetes Beginning or Changed to Insulin Analogue Therapy in Non-Western Countries: The A1chieve Study. Diabetes Research and Clinical Practice, 94, 352-363. http://dx.doi.org/10.1016/j.diabres.2011.10.021
[12] Stratton, I.M., Adler, A.I., Neil, H.A., Matthews, D.R., Manley, S.E., Cull, C.A., et al. (2000) Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study. British Medical Journal, 321, 405-412.
http://dx.doi.org/10.1136/bmj.321.7258.405
[13] Abdel-Aal, N.M., Ahmad, A.T., Froelicher, E.S., Batieha, A.M., Hamza, M.M. and Ajlouni, K.M. (2008) Prevalence of Dyslipidemia in Patients with Type 2 Diabetes in Jordan. Saudi Medical Journal, 29, 1423-1428.
[14] Braun, A., Samann, A., Kubiak, T., Zieschang, T., Kloos, C., Müller, U.A., et al. (2008) Effects of Metabolic Control, Patient Education and Initiation of Insulin Therapy on the Quality of Life of Patients with Type 2 Diabetes Mellitus. Patient Counselling and Health Education, 73, 50-59.
http://dx.doi.org/10.1016/j.pec.2008.05.005                eww141128lx
标签：

评论

发表评论

此博客中的热门博文

Does Immigration Promote the Investment of the Monopolistic Firm?

In the present paper, we examine the effect of increasing uncertainty of immigrants’ growth on the optimal timing of investment of a firm that has a monopolistic power over the labor market. It is revealed that when the uncertainty of immigrants’ growth is more than a threshold level, increasing uncertainty of immigrants’ growth accelerates the optimal timing of firms’ investment and enhances the economic growth, even if the uncertainty of immigrants’ growth is formulated by the geometric Brownian motion, which is in sharp contrast to the standard result that an increase in the uncertainty postpones the optimal timing. With an increase in the immigrants over the past ten years, workforces in the host countries have been growing significantly to the extent that the immigrants represent 70% of the increase in the workforce in Europe, and 47% in the United States as OECD indicates. In the present paper, we attempted to investigate the effect of increased uncertainty caused by the growi...
发表评论
阅读全文

Education Policy Implementation: A Mechanism for Enhancing Primary Education Development in Zanzibar

Education is one of the fundamental rights of individuals; therefore, the government of a country needs to develop and strengthen educational policy and quality as well as to ensure that everyone has equal access to basic education. The improvement of access and quality of education in the world is becoming as an essential factor in development, whereas the basic education (primary school), is acknowledged as a foundation of the higher educational development for every country. To fulfill this goal, governments introduce several policies and procedures; however, it requires some reforms and participation from the politician, policymakers, and other stakeholders to re-examine educational policy so that it can lead to multiplication and betterment of the reforms. Educational reforms actually focus on accountability. A positive educational development and reform is very challenging and needs more effort and strategy on how to use and utilize the resources effectively as such it can achie...
发表评论
阅读全文